An investigator-initiated randomized, placebo-controlled trial, aims to assess BTX-A efficacy in treating Trigeminal neuralgia and the role of biomarkers
Latest Information Update: 07 Oct 2024
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Pain
- Focus Therapeutic Use
- 07 Oct 2024 New trial record
- 09 Aug 2024 Trial design presented at the 20th World Congress on Pain.